Company's Solutions

TempraMed’s first patented product, VIVI Cap; insulin temperature shield pen cap, is scientifically validated, has FDA, CE and other regulatory registrations in place, is already on the market and has been sold to tens of thousands of people worldwide. It is intended for use by the millions that inject insulin and carry it with them everyday, everywhere they go, exposing their insulin to temperatures that can cause degradation. The recently launched VIVI Epi provides temperature protection for epinephrine and solves an unmet need for the millions of people with allergies who depend on EpiPens to save their lives.

TempraMed has a complete pipeline of potential products that will provide a hassle-free solution to a variety of other medications and channels, including biologics, vaccines and dry freeze blood and plasma, among others. The TempraMed patented technology can be applied for safe temperature control for transport of temperature sensitive medications to rural places and for keeping them protected during use.

Prominent Case Study

Preferences for Insulin Storage

Insulin storage options are needed to maintain insulin potency. There are a variety of storage options but many
cause insulin to freeze or require use of water. The VIVI Cap is a new solution that maintains insulin pens at room
temperature for up to 24 hours and response was favorable amongst users.

Insulin is a large peptide molecule with a narrow therapeutic window. Extreme high and low temperatures can
cause insulin to break down and lose potency. This is especially problematic in the summer and winter months.
Insulin is commonly stored in a cooler with ice pack, which makes it susceptible to freezing. There are new
products that protect insulin and maintain it at room temperature.

The specific aims are to determine the reason why people with diabetes chose to purpose a new insulin storage
device and what features they like most about the device.

This was a cross-sectional survey administered to people with diabetes that recently purchased the VIVI Cap which
is a device sold online that stores insulin pens at room temperature for up to 24 hours at time. It does not require
charging and the device is designed to last for several years before needing replacement.

A total of 80 surveys were completed by people that purchased the VIVI Cap between February, 2021 and February, 2022. The average age of participants was between 40-60 years. Common themes of what people like most from the storage solution include: small size, convenience, ease of use, reassurance of insulin temperature, no battery needed, doesn't require refrigeration, and enhanced quality of life. The most common reasons for purchase include for everyday use, for work outside, for a trip, and for outdoor activities.

Storage options are needed for insulin to maintain its temperature and potency. The VIVI Cap offers a solution to maintain insulin at room temperature. People with diabetes purchased for a wide variety of reasons ranging from everyday work to outdoor activities or trips. People like the convenience of use and small size and this offers another option for people with diabetes.